Physician

Anita Varghese, M.D.

According to 2025 Medicare claims, Anita Varghese, M.D. (NPI: 1194152710) practices infectious disease in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is READING HOSPITAL (NPI: 1801478011; TIN: 23-1352204) and primary practice location at 19611-2143. Varghese is affiliated with the Vytalize Health Enhanced ACO LLC (ACO ID: A5300), participating under the MSSP model.

Varghese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 408 traditional Medicare patients, billed 753 HCPCS/CPT codes, and received $54,391 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 316 prescription claims across 79 beneficiaries totaling $396,508 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2020 DME data shows 12 claims. Open Payments data shows 7 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $277,682 to $54,391. In contrast, Part D prescription costs have moved sharply higher in recent years, from $11,797 to $396,508. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	782	2,977	$277,682
2016	768	2,596	$241,068
2017	194	612	$55,238
2018	267	616	$41,848
2019	852	2,044	$131,405
2020	643	1,301	$81,542
2021	N/R	N/R	N/R
2022	285	626	$36,027
2023	373	780	$53,721
2024	408	753	$54,391

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	58	$11,797
2016	23	107	$27,018
2017	163	440	$75,487
2018	270	981	$221,562
2019	469	1,953	$356,874
2020	356	1,687	$217,861
2021	49	158	$11,907
2022	178	737	$1,883,289
2023	118	511	$1,168,591
2024	79	316	$396,508

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	28	$1,036
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	13	$137
2020	N/R	12	$92
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	202	212	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	42	50	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	255	442	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	20	20	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	38	1,140	$142,744
Daptomycin	Daptomycin	27	173	$69,574
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	13	390	$49,254
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	14	420	$48,000
Ertapenem	Ertapenem Sodium	11	61	$8,188

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$151	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anita Varghese, M.D.?

Tedicare shows public-source Medicare data for Anita Varghese, M.D. (NPI 1194152710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita Varghese, M.D. have ACO affiliation data?

Anita Varghese, M.D. is shown with ACO affiliation data for Vytalize Health Enhanced ACO LLC (MSSP, ACO ID A5300).

What billing organization is linked to Anita Varghese, M.D.?

Anita Varghese, M.D. is linked to READING HOSPITAL (billing NPI 1801478011) in the available physician profile data.

Does Anita Varghese, M.D. have Open Payments data?

Anita Varghese, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.